By: Lara Goldstein
Zinger Key Points A comprehensive weekly overview of major moves in business, science, trends and events within the psychedelics sector.
Lara Goldstein is a staff writer for Benzinga and Business Insider. She focuses on covering news and developments in the biotech and pharmaceutical industries, with a particular emphasis on psychedelic-assisted therapies and breakthrough treatments for various medical conditions. Her articles provide insights into the latest research, clinical trials, and industry trends in this rapidly evolving field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Lara Goldstein's coverage is heavily focused on the healthcare and pharmaceutical industry, specifically within the psychedelic sector. Her articles predominantly feature press releases, data citations, and government announcements related to psychedelics.
Given Lara's focus on this niche industry, she would likely be interested in receiving pitches that provide exclusive insights into clinical trials, new treatments or therapies using psychedelics, regulatory changes related to psychedelic reform, as well as profiles of key executives and influencers shaping the psychedelic landscape.
As Lara's geographic focus is not specified but her coverage seems international in scope given the nature of the topics discussed. Therefore, individuals with expertise or unique perspectives within these areas should consider reaching out for potential collaborations.
This information evolves through artificial intelligence and human feedback. Improve this profile .